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Most of the fundamental biological processes involve specific interaction between RNA molecules, both 
protein-coding and noncoding RNAs, and proteins. The RNA-protein interactions results in the formation of 
ribonucleoprotein complexes (RNPs) and altercations in the levels and structure of either can affect the 
associated cellular function.  Recent studies suggest that non-protein coding share of the genome is aggressively 
involved in multiple functions, such as gene expression, chromatin modification, cell proliferation and in a wide 
range of diseases. Further studies on the mechanisms by which ncRNAs operate would yield a wealth of 
information regarding their functional roles and the growing understanding of RNA biology to develop new 
RNA-based tools for developing therapeutics. 
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Introduction 
Ribonucleic acids (RNA) were earlier considered as a 
lowly messenger molecule that carries genetic information 
coded in the deoxy-ribonucleic acid (DNA) to the 
proteins.  However, myriad of discoveries since the late 
1970s demonstrated the versatility of RNA molecules. In 
addition to carrying genetic information, RNA can fold up 
into complex structures that catalyze different chemical 
reaction. These classes of catalytic RNAs are known as 
ribozymes, and the finding earned Thomas Cech and Sidney 
Altman the Nobel Prize in Chemistry in 1989. Furthermore, 
there are RNAs such as ribozymes and riboswitches, which 
bind metal ions and metabolites, and the binding causes 
structural changes in the RNA secondary and tertiary 
structure, leading to its own gene expression variation
 [1,2]
.
All these discoveries demonstrated the emerging role of 
RNAs as the regulators of basic cellular functions
 [3]
. Once it
was discovered that RNA could both carry information as 
well as catalyze chemical reactions, RNA occupied center 
stage leading to the "RNA world" hypothesis. Using 
advanced methods, it has been discovered that intrinsically, 
RNA structure is highly flexible and limited to transitions 
between the few conformations that favor stable base-pairing 
and stacking interactions
 [1, 4, 5]
.
The transcriptome 
For long time it was thought that the transcriptome is 
mainly composed of mRNAs and few regulatory RNAs such 
as tRNAs, rRNAs etc. Nevertheless, recent progresses in 
high-throughput RNA sequencing techniques have revealed 
the complexity of genomes in higher organisms. 
Approximately 22,000 protein-coding genes have been 
identified in the human genome
 [6]
. However, this constitutes
only 2% of the genome and more than 70% of the human 
genome is transcribed into non-protein coding transcripts, 
which was previously considered as genomic junk or noise
[7]
. Noncoding RNAs (ncRNAs) regulate a myriad of
biological functions such as transcription, chromatin 
remodeling, RNA splicing, and translation
 [8]
. Unlike
ribozymes and riboswitches, where the RNA structure itself 
regulates the biological function, most ncRNAs function as 
RNA-protein complexes. Nevertheless, it is no more 
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considered as transcriptional noise but as key regulatory 
layer of molecular function. The noncoding portion of the 
transcriptome is further divided into these following 
categories: miRNAs, piRNAs, snoRNAs, lncRNAs and 
lincRNAs. 
microRNAs in diseases 
The most extensively studied group of ncRNAs are 
microRNAs (miRNAs), which are small ~22 nucleotides (nt) 
duplex RNAs generated from miRNA precursor transcripts 
by processing steps tightly regulated by members of the 
RNAse III family, Drosha and Dicer
 [9,10]
. miRNAs facilitate 
gene silencing by regulating the translation of mRNA into 
proteins
 [11]
. During miRNA mediated translation inhibition, 
one of the two strands of the miRNA is incorporated into the 
active sites of the argonaute proteins. This single strand acts 
as a guide molecule for Watson–Crick base pairing with 
complementary sequences in target mRNAs
 [12]
. miRNAs 
inhibit target mRNA translation by leading the RNA-induced 
silencing complex (RISC) to the 3'untranslated regions 
(UTRs) of target transcripts 
[12]
. Many miRNAs are known to 
regulate the translation of multiple transcripts simultaneously 
and the inhibition of mRNA translation by miRNAs occurs 
in two ways; regulating inhibition of translation initiation and 
transcript degradation 
[12, 13]
. miRNAs are believed to 
modulate translation of more than half of mRNAs which 
makes them regulators of  key processes, including 
development, differentiation, metabolism, aging and 
degeneration
 [12,13]
. There are roughly 2200 miRNA genes 
have been reported to exist in the mammalian genome, and 
from that list over 1000 belong to the human genome
 [14]
. A 
comprehensive review that explains the role of miRNAs as 
important new regulatory molecules in different human 
diseases is discussed elsewhere
 [15]
. 
piRNAs: new layer of cellular regulation 
A new class of noncoding small RNAs recently getting 
attention is the Piwi-interacting RNAs (piRNAs), 
predominantly present in the germline, which interact with 
Piwi proteins
 [16]
. PiRNAs are typically 24-32 nucleotide (nt) 
long and found in Drosophila, zebrafish and mammals
 [17]
. 
PiRNAs are formed from long single-stranded RNA 
precursors that are mostly coded by repetitive intergenic 
sequences in the genome and are formed via a 
Dicer-independent mechanism
 [17]
. PiRNAs seem to play 
vital roles during germline development through a series of 
RNA-mediated mechanisms; mainly epigenetic silencing of 
transposons through DNA methylation 
[17]
. 
Recently, it was reported that piRNA-pathway disorders 
increase the number of repeats of retrotransposon, leading to 
DNA damage
 [18]
. Since DNA damage is a hallmark of tumor 
genesis in germline and somatic cells, piRNAs may be 
dis-regulated and play key roles in tumorigenesis. Recent 
evidence suggests that piRNAs have been identified in 
human cancer cells, where they regulate processes like de 
novo DNA methylation, leading to tumorigenesis
 [19]
. 
Recently, a piRNA named piR-651/823 recognized by 
gastroenterologists is involved in gastric carcinogenesis
 [20]
. 
piR-651/823 also represented as an efficient diagnostic 





Small nucleolar RNAs (SnoRNAs) are a large family of 
moderately well characterized noncoding RNAs (ncRNAs). 
SnoRNAs are involved in the processing of other RNAs, 
such as tRNA, rRNA and small nuclear RNA (snRNAs)
 
[21,22]
. Within the cell, snoRNAs interact with specific 
proteins to form small nucleolarribonucleoprote in particles 
(snoRNPs). Most of the snoRNAs carry two short sequence 
elements, called boxes C and D which are essential for 
binding of a common snoRNP protein component, fibrillarin
 
[23]
.  Recently, it has been reported that snoRNAs and 
fibrillarin are overexpressed in both murine and human 
breast cancer and prostate cancers
 [24]
. The snoRNAs and 
fibrillarin overexpression is in fact driving tumorigenicity in 
vitro and in vivo. Using microarrays and quantitative PCR 
(qPCR), Valleron et al., investigated snoRNA regulation in 
cancer cells 
[25]
. The study found specific patterns of 
snoRNA accumulation in acute myeloblastic and acute 
lymphoblastic leukemias
 [25]
. Furthermore, a recent study 
showed overexpression of six snoRNAs in tumor tissues of 
non-small-cell lung cancer (NSCLC), the leading cause of 
cancer death
 [26]
. Together, these studies indicate that 
snoRNAs have critical role in cancer initiation. Additionally, 
human snoRNA, HBII-52 is associated with two neurological 




Long noncoding RNAs: novel regulators of physiology 
and disease  
Long noncoding RNAs (lncRNAs) are a heterogeneous 
group of noncoding transcripts typically 200 to thousands of 
nucleotides in length. This group of ncRNA constitutes the 
largest portion of the mammalian noncoding transcriptome
 
[28]
. The number of lncRNAs reported in human as well as 
lower organisms is ever expanding and many of these 
lncRNAs are estimated to carry out key functions in 
fundamental cellular processes, thus adding another level of 
complexity to our understanding of genomic regulation
 [28]
. 
The expression pattern and distribution of lncRNAs found to 
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be tissue and cell-type specific, indicating unique functions 
of lncRNAs
 [29, 30]
. Earlier studies had proposed a number of 
different mechanisms by which lncRNAs regulate chromatin 
and transcriptional machinery
 [31]
. A well-known function of 
lncRNAs is to mediate epigenetic modifications of DNA by 
recruiting chromatin remodeling complexes to specific loci
 
[32]
. A classic example is the human HOX loci, where 
temporal and spatial expression of hundreds of lncRNAs is 
highly structured. These lncRNAs regulate chromatin 
accessibility through key processes that involves histone 
modification enzymes and RNA polymerase
 [33]
. Another 
example is the X chromosome inactivation where X-inactive 
specific transcript (XIST) lncRNA recruits the polycomb 
complex to silence the X chromosome from which it is 
transcribed
 [34]
. A lncRNA transcribed from the opposite 
strand to XIST is called TSIX, which play a key role in 
X-chromosome inactivation by regulating expression levels 
of XIST 
 [32]
. A recent study showed that an endogenously 
expressed antisense RNA transcribed from opposite strand of 
APOA1 gene cluster in humans regulates the his tone 
methylation and APOA1 expression in HepG2 cells. 




From emerging studies, it is very evident that lncRNAs 
participate in a wide range of biological processes
 [30]
. Past 
decade in RNA research clearly implies the role of lncRNA 
in nearly every fundamental cellular process from chromatin 
organization, mRNA splicing, RNA degradation, and 
translation. The exact mechanisms by which lncRNAs 
regulate these key functions are still elusive. Multiple lines of 
evidence connect dysfunctions of lncRNAs to diverse human 
diseases
 [36]
. These dysfunctions involve variations in the 
primary and secondary structures that affect the binding or 
association of lncRNA with its target protein, DNA, and/or 
RNA. Additionally, altercations in the expression levels of 
lncRNAs as well as their associated RNA-binding proteins 
can lead to many diseases
 [36]
.  
There are many lncRNAs involved in cell cycle regulation 
and directly linked to various types of cancers. Two 
well-known examples are ANRIL and HOTAIR, both affect 
the chromatin structure by acting as scaffold molecules via 
interaction with chromatin modification complexes
 [37,38]
. 
Overexpression of ANRIL and HOTAIR causes variations to 
the chromatin structure leading to cancer development and 
progression. ANRIL is a lncRNA antisense to 
INK4b/ARF/INK4a locus encodes three tumor suppressor 
genes. A recent study demonstrated the interaction between 
ANRIL and the Pc/Chromobox 7 (CBX7) protein, a key 
member of the polycomb repressive complex 1 (PRC1)
 [39]
. 
The study also showed that there is a correlation between 
reduced INK4a levels and increased levels of both CBX7 and 
ANRIL in prostate cancer tissues
 [39]
. HOTAIR is another 
lncRNA that is involved in chromatin remodeling and there 
is increasing evidence that HOTAIR play vital role in cancer 
progression as increased expression of HOTAIR was reported 
in breast cancer.
 [38, 40]
 HOTAIR interacts with the polycomb 
repressive complex 2 (PRC2) and aberrations in HOTAIR 
expression level cause increased PRC2 repressive activity, 
leading to breast cancer progression
 [38]
. 
MALAT-1 (metastasis-associated in lung adenocarcinoma 
transcript) is another lncRNA that regulates alternative 
splicing as well as transcriptional regulation. MALAT-1 
regulates the cellular distribution of pre-mRNA splicing 
factors to nuclear speckles, via modulating phosphorylation 
of specific proteins
 [41]
. MALAT-1 is highly abundant in 
central nervous system where it regulates neuronal synapse 
formation, density and maturation 
[42]
, thus affecting 
synaptogenesis. So far multiple studies showed that MALAT1 
is involved in lung and colorectal cancer metastasis
 [43, 44]
. 
Beta-site amyloid precursor protein (APP)-cleaving 
enzyme 1 (BACE1) is an aspartyl protease that cleaves APP 
at the β-site in the formation of amyloid β-peptide (Aβ). 
Buildup of the Aβ neuropeptide has been associated with 
many neurological disorders, underscoring the significance 
of BACE1 regulation
 [45]
. The antisense lncRNA of BACE1 
(BACE1-AS) is transcribed from the opposite strand of 
BACE1. Emerging studies suggested elevated levels of Aβ, 
BACE1 proteins, and BACE1-AS had been identified in 
patients with Alzheimer's disease (AD). BACE1-AS is an 
example where altered expression levels of lncRNA play a 




Increasing number of studies has shown that ncRNAs 
have important roles in cellular physiology and are 
associated with a wide range of diseases. NcRNAs are now 
becoming potential targets for disease diagnosis and 
prognosis. While there are thousands of ncRNA identified in 
the past, only a few are reported to be involved in the 
development and progression of diseases. One caveat is the 
lack of knowledge about the molecular mechanisms by 
which these ncRNAs operate. Currently, bioinformatics 
methods are used to predict potential associations of ncRNAs 
with protein coding genes and their role in different diseases. 
More and more studies that dissect the molecular 
mechanisms of ncRNAs will hopefully shine more light onto 
the ncRNA mediated cellular processes in the near future. 
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